BioExel Programme 2019 Introduces New Cohort of MedTech Companies

Pictured at the launch of the 2019 BioExel Programme at NUI Galway are: L-r back row: Bernice Crowley, BioExel, Barry Egan, Enterprise Ireland, Gillian Buckley, Western Development Commission, Sandra Ganly, Bioexel, Robert Rosenberg, BioExel Entrepreneur in Residence and Fiona Neary, BioExel. L-r front row: Maria Jennings, Enterprise Ireland and Donal Cahalane, Galway University Foundation, NUI Galway.
Feb 05 2019 Posted: 11:12 GMT

A new wave of Medtech companies supported by NUI Galway’s BioExel programme, Ireland’s first Medtech accelerator continues following the success of 2018 cohort

Following on from the success of the inaugural 2018 NUI Galway BioExel programme, a second successful recruitment campaign was completed last December. A high calibre of applications were reviewed from across the globe and the final eight companies are now immersed in the 2019 BioExel accelerator programme.

 BioExel offers €95,000 in seed funding to successful applicants along with six-months of intensive training, mentoring, lab space and supported interactions with potential investors. The programme allows participants to build and commercially validate their technologies by working with existing entrepreneurial networks, mentors and management team.

BioExel is managed by MedTech Director, Dr Sandra Ganly, also a co-founder of BioInnovate Ireland and Senior Research Fellow in NUI Galway, and Fiona Neary, Commercial Director and co-founder of BioExel, and Innovation Operations Manager at NUI Galway.

Fiona Neary at NUI Galway, said: “BioExel’s mission is to act as an honest broker between Medtech start-ups and the investment community bridging the gap between technology de-risking and raising investment. BioExel has positioned itself as an internationally recognised Medtech accelerator with the reputation of significantly enhancing indigenous Medtech start-ups by providing attractive seed investment funding and a pipeline of next generation Medtech start-up’s for Ireland.”

Joe Healy, HPSU Divisional Manager, Enterprise Ireland, said: “Ireland has a growing reputation in MedTech start-ups and the west of Ireland is renowned globally as a top medical device cluster. The sector is an important contributor to our economic growth and BioExel is uniquely positioned to provide essential support for the new innovative start-ups in this sector. We are delighted to continue our support for the programme, and the companies who take part as they take their first steps towards building scale and expanding their reach.”

Joined by the funding partners last month at NUI Galway, the programme officially launched the new cohort of BioExel 2019 and enabled a great working session where partners and participants came together to share experiences and business opportunities.

BioExel 2019 Companies:

  • Áine Behan and Fred Herrera, CortechsConnect Ltd, an Irish based company developing a non-pharmacological Attention-Deficit/Hyperactivity Disorder (ADHD) intervention. Visit:
  • Declan Trumble, Kudos Health, an Irish based company developing a Health and Wellness engagement platform. Visit:
  • Idicula Mathew, Hera Health Solutions, a US based company developing a Biodegradable Female Contraceptive Implant. Visit:
  • Chris Duke and Michael Newell, Lifestyle Medical, an Irish based company developing Knee kinematics performance and rehabilitation technology.
  • Liam McMorrow, Adelie Health, a UK technology and new Irish start-up, developing an innovative Smart Insulin Pen. Visit:
  • Blaine Doyle, Glow Dx, an Irish company with an export market in place developing an Infectious Disease Diagnostic Platform. Visit:
  • Rory Clerkin and Morris Black, Holywood Medical, an Irish based company developing Migraine prediction assay (predicts the onset of migraine) for preventative medicine in this space. Visit:
  • Damien Kilgannon, Sula Health, an Irish based company developing a solution in the area of Circadian Rhythm (Sleep) Disorder Treatment. Visit:

This new cohort of companies will take part in the BioExel accelerator programme until June 2019, preparing them to be investor ready or to have investment in place.

BioExel is a partnership programme funded by Enterprise Ireland, Western Development Commission, Galway University Foundation, Bank of Ireland Seed and Early Stage Equity Fund, and hosted by NUI Galway.

For additional information please contact the BioExel team at or phone 087 6226240 or visit:


Marketing and Communications Office


Featured Stories